Virtual biotech deploys 37,000 AI agents across drug discovery
A Stanford-developed virtual biotech used 37,000 AI agents to analyze 50,000 trials, identify markers linked to drug success and design ...
A Stanford-developed virtual biotech used 37,000 AI agents to analyze 50,000 trials, identify markers linked to drug success and design ...
In the rapidly evolving landscape of clinical trials, integrating machine learning (ML) and artificial intelligence (AI) has long been heralded ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine